Celsius Therapeutics, Inc. clinical trials
Acquired by AbbVie, Jun 27, 2024 · source ↗
The registry lists 1 studies whose lead sponsor is Celsius Therapeutics, Inc.. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Feb 9, 2024.
Before and after it joined AbbVie
- First submitted before Celsius Therapeutics, Inc. became part of AbbVie
- 1
- First submitted after Celsius Therapeutics, Inc. became part of AbbVie
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Celsius Therapeutics, Inc.1 study
Something wrong with this grouping? Tell us on the AbbVie page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All AbbVie studies →
- First-in-human, Single Ascending Dose Study of CEL383 in Healthy Adult SubjectsCompletedNCT05901883Phase 1
Sponsor listed in the registry: Celsius Therapeutics, Inc. · First submitted before Celsius Therapeutics, Inc. became part of AbbVie